Tumori (TUMORI )
- Impact factor0.92Show impact factor historyHide impact factor history
- 5-year impact1.00
- Cited half-life7.20
- Immediacy index0.08
- Article influence0.28
- WebsiteTumori website
- Material typePeriodical, Internet resource
- Document typeInternet Resource, Computer File, Journal / Magazine / Newspaper
Publications in this journal
- Tumori 12/2013; 99.
- [show abstract] [hide abstract]
ABSTRACT: Abstract Aims and background. To summarize current knowledge on psychopharmacological and psychotherapeutic options for patients with breast cancer and comorbid depression, starting from the psychiatric viewpoint. Issues on diagnostic boundaries of depression and outcome measures are raised. Methods. We completed a literature review from the last 30 years (until March 2012) using PubMed by pairing the key words: 'breast cancer and depression treatment' (about 1431 works, including 207 reviews), 'breast cancer and antidepressants' (about 305 works, including 66 reviews), and in particular 'selective serotonin reuptake inhibitors and breast cancer' (38 works, including 10 reviews) and 'breast cancer and psychotherapy' (603 works, including 84 reviews). Papers in the English language were selected, including recent reviews. Results. There is little evidence for the superiority of any one specific intervention with pharmacological options or psychotherapy. The heterogeneity of assessment criteria, the small number of subjects collected in systematic studies, the difficulty in adopting standardized outcome measures, and the limited numbers of available drugs with a favorable side effect profile are the main limitations that emerge from the literature. No conclusive findings are available on mid-term/long-term treatment strategies, or when depression is part of a bipolar disorder. Conclusions. Further research is necessary to define the most appropriate approach to depression when it occurs in comorbidity with breast cancer. A more accurate definition of the clinical phenotypes of depression in the special population of patients with breast cancer is suggested as a key issue.Tumori 09/2013; 99(5):623-33.
- [show abstract] [hide abstract]
ABSTRACT: The case of a 72 year old woman with primary malignant melanoma of the esophagus, subjected twice to surgical operation with a 17-month interval and still alive 35 months after the onset symptoms is reported. In order to outline the biologic behaviour of this rare neoplasm, 44 similar bibliographic cases are analysed and comparisons made between melanoma and carcinoma of the esophagus as well as between melanomas of the esophagus and of the skin.Tumori 06/2013; 61(2):163-72.
- Tumori 03/2013; 99(2):e55-60.
- Tumori 01/2013; 99:e14-18.
- Tumori 03/2012; 98(2):46e-49e.
- Tumori 11/2011; 97(6):36e-8e.
- Tumori 03/2011; 97(2):177-84.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.
ISSN: 1942-7522, Impact factor: 1.03
Mary Ann Liebert
ISSN: 1931-843X, Impact factor: 1.42
ISSN: 1879-1913, Impact factor: 3.58
ISSN: 1878-7886, Impact factor: 1.17
International Center for Cancer...
ISSN: 1791-2423, Impact factor: 2.66
Nature Publishing Group
ISSN: 1759-4820, Impact factor: 4.79
British Institute of Radiology;...
ISSN: 1748-880X, Impact factor: 2.11
ISSN: 1744-8328, Impact factor: 2.07